 |
|
ORIGINAL ARTICLE |
|
| Year : 2016 | Volume
: 11
| Issue : 3 | Page : 211-213 |
|
| Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection |
|
|
Ali H Hajeer1, Hanan Balkhy2, Sameera Johani3, Mohammed Z Yousef4, Yaseen Arabi5
1 Department of Basic Medical Sciences, King Saud bin Abdulaziz University for Health Sciences; Department of Pathology and Laboratory, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia
2 Department of Infection Prevention and Control, King Saud bin Abdulaziz University for Health Science; King Abdullah International Medical Research Center, King Abdulaziz Medical City, 5Department of Intensive Care, King Abdulaziz Medical City, Riyadh, Saudi Arabia
3 Department of Pathology and Laboratory, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia
4 Department of Basic Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
5 King Abdullah International Medical Research Center, King Abdulaziz Medical City; Department of Intensive Care, King Abdulaziz Medical City, Riyadh, Saudi Arabia
| Date of Submission | 14-Apr-2016 |
| Date of Acceptance | 01-May-2016 |
| Date of Web Publication | 7-Jul-2016 |
Correspondence Address:
Ali H Hajeer
Department of Basic Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, P. O. Box: 3660 Riyadh 11481
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1817-1737.185756
|
|
 Abstract | | |
Background: Middle East Respiratory Syndrome (MERS) is a disease of the lower respiratory tract and is characterized by high mortality. It is caused by a beta coronavirus (CoV) referred to as MERS-CoV. Majority of MERS-CoV cases have been reported from Saudi Arabia.
Aim: We investigated the human leukocyte antigen (HLA) Class II alleles in patients with severe MERS who were admitted in our Intensive Care Unit.
Methods: A total of 23 Saudi patients with severe MERS-CoV infection were typed for HLA class II, results were compared with those of 161 healthy controls.
Results: Two HLA class II alleles were associated with the disease; HLA-DRB1*11:01 and DQB1*02:02, but not with the disease outcome.
Conclusions: Our results suggest that the HLA-DRB1*11:01 and DQB1*02:02 may be associated with susceptibility to MERS.
Keywords: Human leukocyte Antigen Class II, Middle East respiratory syndrome-coronavirus, Saudi Arabia
How to cite this article:
Hajeer AH, Balkhy H, Johani S, Yousef MZ, Arabi Y. Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection. Ann Thorac Med 2016;11:211-3 |
How to cite this URL:
Hajeer AH, Balkhy H, Johani S, Yousef MZ, Arabi Y. Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection. Ann Thorac Med [serial online] 2016 [cited 2022 Aug 16];11:211-3. Available from: https://www.thoracicmedicine.org/text.asp?2016/11/3/211/185756 |
Middle East respiratory syndrome (MERS) is caused by a novel coronavirus (MERS-CoV).[1] In Saudi Arabia, Zaki et al. reported the first case of MERS presenting with acute pneumonia that subsequently lead to renal failure and fatal outcome.[1] This was followed by multiple outbreaks although so far the majority of the reported cases are from Saudi Arabia.[2] MERS presents as acute respiratory syndrome, but majority of cases suffer from shock, acute kidney injury, and thrombocytopenia which lead to high morbidity.[3] It is unclear whether the clustering of cases in Saudi Arabia is related to host genetic predisposition such as the human leukocyte antigen ( HLA).
HLA Class I and II genes encode protein receptors that orchestrate the immune response by presenting foreign or modified self-antigens to T-cells.[4] MERS-CoV is closely related to severe acute respiratory syndrome coronavirus (SARS-CoV). Studies on the HLA associations in SARS showed conflicting results. Xiong et al. showed no HLA allele association in 95 Chinese SARS patients,[5] whereas Lin et al. showed that severe SARS was associated with HLA-B*46:01 in Taiwanese patients.[6]
To date, it remains unclear why most cases have been reported in Saudi Arabia although evidence for infection among camels have been demonstrated in a much geographically dispersed area including East Africa and Spain.[7] In addition, it remains unclear why some patients develop severe MERS-CoV illness with high mortality.
In this study, we recruited MERS patients admitted to Intensive Care Unit (ICU) at King Abdulaziz Medical City to study the association between HLA Class II alleles and severe MERS disease.
| Methods | |  |
This study comprised 23 consecutive Saudi MERS patients admitted to ICU at King Abdulaziz Medical City, Riyadh. All patients confirmed to have laboratory-confirmed MERS-CoV infection by real-time reverse transcription-polymerase chain reaction of nasopharyngeal swabs or tracheal aspirates (TIB Molbiol GMbH, Berlin, Germany). The study was approved by the local Institutional Review Board Committee and written informed consent was obtained from the patient or next of kin.
Control group
A group of 161 healthy individuals were available for comparison. All were Saudi with a mean age of 36 years and almost equal distribution of male and female gender.
Human leukocyte antigen-typing
HLA typing was carried out using high definition kits LABType ® SSO HD (One Lambda Inc., Canoga Park, CA, USA). The HLA typing was carried out according to the manufacturers' instructions. Briefly, the HLA typing procedure comprised DNA extraction, amplification, hybridization, reading on a Luminex machine (LABScan™ 100, One Lambda, Canoga Park, CA, USA), and interpretation was carried out using HLA Fusion™ software (One Lambda, Canoga Park, CA, USA).
Statistical analysis
Statistical analysis was carried out using STATA 12.0 software (Stata Corporation, College Station, TX, USA). Differences in the HLA-DRB1 and HLA-DQB1 allele frequencies between two groups were compared using Fisher's exact test separately for all alleles and P < 0.05 was considered to be statistically significant, after Bonferroni correction for multiple testing. Odds ratio (OR) and 95% confidence interval (CI) were calculated using 2 × 2 tables.
| Results | | |
As can be seen from [Table 1], most patients were male and old with very high mortality. The comparison of HLA-DRB1 results between cases and controls revealed one association. HLA-DRB1*11:01 carried a significant association with severe MERS in this Saudi cohort (OR = 6.11, 95% CI 1.36-24.76, P = 0.0016, P c = 0.022) [Table 2]. HLA-DRB1*04:03, 04:05, and 13:02 alleles were overrepresented in the MERS cases but did not reach statistical significance. [Table 3] demonstrates the comparison between the cases and controls for the HLA-DQB1 alleles. HLA-DQB1*02:02 showed positive association with severe MERS infection (OR = 2.64, 95% CI 0.99-7.10, P = 0.027, P c = 0.27) but this association did not reach significance after correcting for multiple allele testing [Table 3]. HLA-DQB1*02:01, 05:01, and 05:02 allele frequencies were reduced in the cases compared to controls but did not reach statistical significance, whereas HLA-DQB1*03:01, 03:02, 06:02, and 06:04 were raised in the cases compared to controls but again did not reach statistical significance [Table 3]. | Table 1: Demographic characteristics of Middle East respiratory syndrome patients
Click here to view |
 | Table 2: Distribution of HLA-DRB1 alleles in Middle East respiratory syndrome-coronavirus patients and controls*
Click here to view |
 | Table 3: Distribution of HLA-DQB1 alleles in Middle East respiratory syndrome-coronavirus patients and controls*
Click here to view |
| Discussion | | |
Until today, the vast majority of MERS-CoV cases came from Saudi Arabia.[2] The disease is so severe affecting mainly elderly people with comorbidity. Arabs have HLA allele and haplotype distribution that is different from other ethnicities, for example, the HLA-A2, B50, DR7 alleles and haplotype are found mainly in Arabs.[8] Up to our knowledge, this is the first report on HLA associations with MERS infection. Our results demonstrate the association of severe MERS with HLA Class II alleles, namely DRB1*11:01 and DQB1*02:02. These alleles are also common in the Korean population [9] where the second biggest outbreak of MERS infection occurred.[10]
Multiple logistic regression analysis revealed no association between any of the HLA alleles and 28-day mortality (data not shown).
Conflicting results on HLA association were reported in SARS infection; a closely related emerging corona virus. While Xiong et al. and Ng et al.[5],[11] reported no HLA associations, others showed association with HLA-A*46:01.[6]
| Conclusion | | |
Here, we show association between severe MERS infection and HLA Class II alleles. Our sample size is small and this is one of the major limitations of this study. Studies with larger sample size are needed to evaluate these associations.
Acknowledgment
We would like to thank Dr. Musharaf Sadat for her help in collecting the demographic data of the patients.
This work was sponsored by a grant from KAIMRC.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367:1814-20.  |
| 2. | Al-Tawfiq JA, Memish ZA. Middle East respiratory syndrome coronavirus: Epidemiology and disease control measures. Infect Drug Resist 2014;7:281-7. |
| 3. | Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 2014;160:389-97. |
| 4. | Klein J, Sato A. The HLA system. First of two parts. N Engl J Med 2000;343:702-9. |
| 5. | Xiong P, Zeng X, Song MS, Jia SW, Zhong MH, Xiao LL, et al. Lack of association between HLA-A,-B and-DRB1 alleles and the development of SARS: A cohort of 95 SARS-recovered individuals in a population of Guangdong, Southern China. Int J Immunogenet 2008;35:69-74. |
| 6. | Lin M, Tseng HK, Trejaut JA, Lee HL, Loo JH, Chu CC, et al. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet 2003;4:9. |
| 7. | Chastel C. Middle East respiratory syndrome (MERS): Bats or dromedary, which of them is responsible? Bull Soc Pathol Exot 2014;107:69-73. |
| 8. | Hajeer AH, Al Balwi MA, Aytül Uyar F, Alhaidan Y, Alabdulrahman A, Al Abdulkareem I, et al. HLA-A,-B,-C,-DRB1 and-DQB1 allele and haplotype frequencies in Saudis using next generation sequencing technique. Tissue Antigens 2013;82:252-8. |
| 9. | In JW, Roh EY, Oh S, Shin S, Park KU, Song EY. Allele and haplotype frequencies of human leukocyte antigen-A,-B,-C,-DRB1, and-DQB1 from sequence-based DNA typing data in koreans. Ann Lab Med 2015;35:429-35. |
| 10. | Cowling BJ, Park M, Fang VJ, Wu P, Leung GM, Wu JT. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill 2015;20:7-13. |
| 11. | Ng MH, Cheng SH, Lau KM, Leung GM, Khoo US, Zee BC, et al. Immunogenetics in SARS: A case-control study. Hong Kong Med J 2010;16 5 Suppl 4:29-33. |
[Table 1], [Table 2], [Table 3] |
|
| This article has been cited by | | 1 |
Immunopathogenecity in COVID-19 |
|
| Saqib Bashir, Aroos Rashid | | Southeast Asian Journal of Case Report and Review. 2022; 8(1): 3 | | [Pubmed] | [DOI] | | | 2 |
The COVID-19 pandemic: an increased risk of rheumatoid arthritis |
|
| Archana Tripathy, Nitish Swain, Bhawna Gupta | | Future Virology. 2021; 16(6): 431 | | [Pubmed] | [DOI] | | | 3 |
Innate and Adaptive Immune Genes Associated with MERS-CoV Infection in Dromedaries |
|
| Sara Lado, Jean P. Elbers, Martin Plasil, Tom Loney, Pia Weidinger, Jeremy V. Camp, Jolanta Kolodziejek, Jan Futas, Dafalla A. Kannan, Pablo Orozco-terWengel, Petr Horin, Norbert Nowotny, Pamela A. Burger | | Cells. 2021; 10(6): 1291 | | [Pubmed] | [DOI] | | | 4 |
Back to basics in COVID-19: Antigens and antibodies—Completing the puzzle |
|
| Monica Neagu, Daniela Calina, Anca Oana Docea, Carolina Constantin, Tommaso Filippini, Marco Vinceti, Nikolaos Drakoulis, Konstantinos Poulas, Taxiarchis Konstantinos Nikolouzakis, Demetrios A. Spandidos, Aristidis Tsatsakis | | Journal of Cellular and Molecular Medicine. 2021; 25(10): 4523 | | [Pubmed] | [DOI] | | | 5 |
The influence of HLA genotype on the severity of COVID-19 infection |
|
| David J. Langton, Stephen C. Bourke, Benedicte A. Lie, Gabrielle Reiff, Shonali Natu, Rebecca Darlay, John Burn, Carlos Echevarria | | HLA. 2021; 98(1): 14 | | [Pubmed] | [DOI] | | | 6 |
HLA-A
homozygosis is associated with susceptibility to
COVID
-19
|
|
| Renato De Marco, Tathyane C. Faria, Karina L. Mine, Marina Cristelli, José O. Medina-Pestana, Hélio Tedesco-Silva, Maria Gerbase-DeLima | | HLA. 2021; 98(2): 122 | | [Pubmed] | [DOI] | | | 7 |
Comparative Analysis of Susceptibility and Severity of COVID-19 in Countries from the Eastern and the Western World Till March ‘21 |
|
| Shashi Chawla, Shubhaa Chawla | | Microbiology Insights. 2021; 14: 1178636121 | | [Pubmed] | [DOI] | | | 8 |
Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review |
|
| Jyoti Choudhary, Shrivardhan Dheeman, Vipin Sharma, Prashant Katiyar, Santosh Kumar Karn, Manoj Kumar Sarangi, Ankit Kumar Chauhan, Gaurav Verma, Nitin Baliyan | | Biological Procedures Online. 2021; 23(1) | | [Pubmed] | [DOI] | | | 9 |
Systems serology detects functionally distinct coronavirus antibody features in children and elderly |
|
| Kevin J. Selva, Carolien E. van de Sandt, Melissa M. Lemke, Christina Y. Lee, Suzanne K. Shoffner, Brendon Y. Chua, Samantha K. Davis, Thi H. O. Nguyen, Louise C. Rowntree, Luca Hensen, Marios Koutsakos, Chinn Yi Wong, Francesca Mordant, David C. Jackson, Katie L. Flanagan, Jane Crowe, Shidan Tosif, Melanie R. Neeland, Philip Sutton, Paul V. Licciardi, Nigel W. Crawford, Allen C. Cheng, Denise L. Doolan, Fatima Amanat, Florian Krammer, Keith Chappell, Naphak Modhiran, Daniel Watterson, Paul Young, Wen Shi Lee, Bruce D. Wines, P. Mark Hogarth, Robyn Esterbauer, Hannah G. Kelly, Hyon-Xhi Tan, Jennifer A. Juno, Adam K. Wheatley, Stephen J. Kent, Kelly B. Arnold, Katherine Kedzierska, Amy W. Chung | | Nature Communications. 2021; 12(1) | | [Pubmed] | [DOI] | | | 10 |
Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature |
|
| Filippo Migliorini, Ernesto Torsiello, Filippo Spiezia, Francesco Oliva, Markus Tingart, Nicola Maffulli | | European Journal of Medical Research. 2021; 26(1) | | [Pubmed] | [DOI] | | | 11 |
Molecular Insights into the Crosstalk Between Immune Inflammation Nexus and SARS-CoV-2 Virus |
|
| Pritha Bose, Priyashree Sunita, Shakti P. Pattanayak | | Current Microbiology. 2021; 78(11): 3813 | | [Pubmed] | [DOI] | | | 12 |
The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19) |
|
| Rasoul Mirzaei, Adeleh Attar, Saher Papizadeh, Ali Salimi Jeda, Seyed Reza Hosseini-Fard, Elaheh Jamasbi, Sima Kazemi, Saman Amerkani, Gholam Reza Talei, Pouya Moradi, Saba Jalalifar, Rasoul Yousefimashouf, Mohammad Akhter Hossain, Hossein Keyvani, Sajad Karampoor | | Archives of Virology. 2021; 166(7): 1819 | | [Pubmed] | [DOI] | | | 13 |
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection |
|
| Seyed Mohammad Ali Hashemi, Marijn Thijssen, Seyed Younes Hosseini, Alijan Tabarraei, Mahmoud Reza Pourkarim, Jamal Sarvari | | Archives of Virology. 2021; 166(8): 2089 | | [Pubmed] | [DOI] | | | 14 |
MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population |
|
| Shay Ben Shachar, Noam Barda, Sigal Manor, Sapir Israeli, Noa Dagan, Shai Carmi, Ran Balicer, Bracha Zisser, Yoram Louzoun | | Journal of Clinical Immunology. 2021; 41(6): 1154 | | [Pubmed] | [DOI] | | | 15 |
Transnasal endoscopic skull base surgery in the COVID-19 era: Recommendations for increasing the safety of the method |
|
| Tomasz Lyson, Joanna Kisluk, Marek Alifier, Barbara Politynska-Lewko, Andrzej Sieskiewicz, Jan Kochanowicz, Joanna Reszec, Jacek Niklinski, Marek Rogowski, Joanna Konopinska, Zenon Mariak, Ricardo L. Carrau | | Advances in Medical Sciences. 2021; 66(1): 221 | | [Pubmed] | [DOI] | | | 16 |
Predictive immunogenetic markers in COVID-19 |
|
| Mauro de Meira Leite, Faviel F. Gonzalez-Galarza, Bruno Conde Costa da Silva, Derek Middleton, Eduardo José Melo dos Santos | | Human Immunology. 2021; 82(4): 247 | | [Pubmed] | [DOI] | | | 17 |
Risk HLA alleles in South America and potential new epitopes for SARS-CoV2 |
|
| Samantha Sáenz Hinojosa, Vanessa Romero | | Human Immunology. 2021; 82(8): 561 | | [Pubmed] | [DOI] | | | 18 |
Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms |
|
| Irma Saulle, Chiara Vicentini, Mario Clerici, Mara Biasin | | Human Immunology. 2021; 82(8): 551 | | [Pubmed] | [DOI] | | | 19 |
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview |
|
| Leila Mohamed Khosroshahi, Mohsen Rokni, Tahmineh Mokhtari, Farshid Noorbakhsh | | International Immunopharmacology. 2021; 93: 107364 | | [Pubmed] | [DOI] | | | 20 |
Association of HLA class I and II genes with Middle East respiratory syndrome coronavirus infection in Koreans |
|
| In-Cheol Baek, Eun-Jeong Choi, Dong-Hwan Shin, Hyoung-Jae Kim, Haeyoun Choi, Hyoung-Shik Shin, Dong-Gyun Lim, Tai-Gyu Kim | | Immunity, Inflammation and Disease. 2021; | | [Pubmed] | [DOI] | | | 21 |
Variants in ACE2; potential influences on virus infection and COVID-19 severity |
|
| Behnaz Bakhshandeh, Shokufeh Ghasemian Sorboni, Amir-Reza Javanmard, Seyed Saeed Mottaghi, Mohammad-reza Mehrabi, Farzaneh Sorouri, Ardeshir Abbasi, Zohreh Jahanafrooz | | Infection, Genetics and Evolution. 2021; 90: 104773 | | [Pubmed] | [DOI] | | | 22 |
The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies |
|
| Zahra Payandeh, Niloufar Mohammadkhani, Mohsen Nabi Afjadi, Saeed Khalili, Masoumeh Rajabibazl, Zahra Houjaghani, Masoomeh Dadkhah | | Expert Review of Anti-infective Therapy. 2021; 19(7): 899 | | [Pubmed] | [DOI] | | | 23 |
Genomics in Patient Care and Workforce Decisions in High-Level Isolation Units: A Survey of Healthcare Workers |
|
| Jennifer E. Gerber, Gail Geller, Angie Boyce, Lisa L. Maragakis, Brian T. Garibaldi | | Health Security. 2021; 19(3): 318 | | [Pubmed] | [DOI] | | | 24 |
COVID-19: Molecular and Cellular Response |
|
| Shamila D. Alipoor, Esmaeil Mortaz, Hamidreza Jamaati, Payam Tabarsi, Hasan Bayram, Mohammad Varahram, Ian M. Adcock | | Frontiers in Cellular and Infection Microbiology. 2021; 11 | | [Pubmed] | [DOI] | | | 25 |
Role of the cellular immunity in the formation of the immune response in coronavirus infections |
|
| I. A. Ivanova, N. D. Omelchenko, A. V. Filippenko, A. A. Trufanova, A. K. Noskov | | Medical Immunology (Russia). 2021; 23(6): 1229 | | [Pubmed] | [DOI] | | | 26 |
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past |
|
| Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, Dipyaman Ganguly, Samit Chattopadhyay | | Frontiers in Immunology. 2020; 11 | | [Pubmed] | [DOI] | | | 27 |
A role for human leucocyte antigens in the susceptibility to SARS-Cov-2 infection observed in transplant patients |
|
| Kay Poulton, Paul Wright, Pamela Hughes, Sinisa Savic, Matthew Welberry Smith, Malcolm Guiver, Muir Morton, David Dellen, Eleni Tholouli, Robert Wynn, Brendan Clark | | International Journal of Immunogenetics. 2020; 47(4): 324 | | [Pubmed] | [DOI] | | | 28 |
The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity |
|
| Inna G. Ovsyannikova, Iana H. Haralambieva, Stephen N. Crooke, Gregory A. Poland, Richard B. Kennedy | | Immunological Reviews. 2020; 296(1): 205 | | [Pubmed] | [DOI] | | | 29 |
SARS-CoV-2 genomic variations associated with mortality rate of COVID-19 |
|
| Yujiro Toyoshima, Kensaku Nemoto, Saki Matsumoto, Yusuke Nakamura, Kazuma Kiyotani | | Journal of Human Genetics. 2020; 65(12): 1075 | | [Pubmed] | [DOI] | | | 30 |
Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19) |
|
| Omalla A. Olwenyi, Shetty Ravi Dyavar, Arpan Acharya, Anthony T. Podany, Courtney V. Fletcher, Caroline L. Ng, St Patrick Reid, Siddappa N. Byrareddy | | Journal of Molecular Medicine. 2020; 98(10): 1369 | | [Pubmed] | [DOI] | | | 31 |
Molecular immune pathogenesis and diagnosis of COVID-19 |
|
| Xiaowei Li, Manman Geng, Yizhao Peng, Liesu Meng, Shemin Lu | | Journal of Pharmaceutical Analysis. 2020; 10(2): 102 | | [Pubmed] | [DOI] | | | 32 |
Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients |
|
| Ignacio Iturrieta-Zuazo, Claudia Geraldine Rita, Ana García-Soidán, Ana de Malet Pintos-Fonseca, Nieves Alonso-Alarcón, Roberto Pariente-Rodríguez, Amalia Tejeda-Velarde, Sergio Serrano-Villar, José Luis Castañer-Alabau, Israel Nieto-Gañán | | Clinical Immunology. 2020; 219: 108572 | | [Pubmed] | [DOI] | | | 33 |
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review |
|
| Esteban Ortiz-Prado, Katherine Simbaña-Rivera, Lenin Gómez- Barreno, Mario Rubio-Neira, Linda P. Guaman, Nikolaos C Kyriakidis, Claire Muslin, Ana María Gómez Jaramillo, Carlos Barba-Ostria, Doménica Cevallos-Robalino, Hugo Sanches-SanMiguel, Luis Unigarro, Rasa Zalakeviciute, Naomi Gadian, Andrés López-Cortés | | Diagnostic Microbiology and Infectious Disease. 2020; 98(1): 115094 | | [Pubmed] | [DOI] | | | 34 |
Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis |
|
| Emilio Di Maria, Andrea Latini, Paola Borgiani, Giuseppe Novelli | | Human Genomics. 2020; 14(1) | | [Pubmed] | [DOI] | | | 35 |
Molecular basis of COVID-19 pathogenesis |
|
| Fedor N. Novikov, Viktor S. Stroylov, Igor V. Svitanko, Vladimir E. Nebolsin | | Russian Chemical Reviews. 2020; 89(8): 858 | | [Pubmed] | [DOI] | | | 36 |
COVID-19 Infection: Concise Review Based on the Immunological Perspective |
|
| Parisa Lotfinejad, Zahra Asadzadeh, Shiva Najjary, Mohammad Hossein Somi, Khalil Hajiasgharzadeh, Ahad Mokhtarzadeh, Afshin Derakhshani, Elmira Roshani, Behzad Baradaran | | Immunological Investigations. 2020; : 1 | | [Pubmed] | [DOI] | | | 37 |
Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) |
|
| Feng-Yee Chang, Hsiang-Cheng Chen, Pei-Jer Chen, Mei-Shang Ho, Shie-Liang Hsieh, Jung-Chung Lin, Fu-Tong Liu, Huey-Kang Sytwu | | Journal of Biomedical Science. 2020; 27(1) | | [Pubmed] | [DOI] | | | 38 |
Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19 |
|
| Simona Pisanti, Joris Deelen, Anna Maria Gallina, Mariella Caputo, Marianna Citro, Mario Abate, Nicoletta Sacchi, Carmine Vecchione, Rosanna Martinelli | | Journal of Translational Medicine. 2020; 18(1) | | [Pubmed] | [DOI] | | | 39 |
COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies |
|
| Abdur Rauf, Tareq Abu-Izneid, Ahmed Olatunde, Anees Ahmed Khalil, Fahad A. Alhumaydhi, Tabussam Tufail, Mohammad Ali Shariati, Maksim Rebezov, Zainab M. Almarhoon, Yahia N. Mabkhot, Abdulrhman Alsayari, Kannan R. R. Rengasamy | | International Journal of Environmental Research and Public Health. 2020; 17(21): 8155 | | [Pubmed] | [DOI] | | | 40 |
Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity |
|
| Andrea Picchianti Diamanti, Maria Manuela Rosado, Claudio Pioli, Giorgio Sesti, Bruno Laganà | | International Journal of Molecular Sciences. 2020; 21(9): 3330 | | [Pubmed] | [DOI] | | | 41 |
COVID-19: A Devastating Pandemic
|
|
| Punet Kumar, Md Iftekhar Ahmad, Sangam Singh | | Pharmaceutical Sciences. 2020; 26(Covid-19): S3 | | [Pubmed] | [DOI] | | | 42 |
Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future |
|
| Rohit Shetty, Arkasubhra Ghosh, SantoshG Honavar, Pooja Khamar, Swaminathan Sethu | | Indian Journal of Ophthalmology. 2020; 68(5): 693 | | [Pubmed] | [DOI] | | | 43 |
Incidence and Immunologic Analysis of Coronavirus Disease (COVID-19) in Hemodialysis Patients: A Single-Center Experience |
|
| hande arslan, Ugur Musabak, Ebru H. Ayvazoglu Soy, Ozlem Kurt Azap, Burak Sayin, Sule Akcay, K. Murat Haberal, Aydincan Akdur, Sedat Yildirim, Mehmet Haberal | | Experimental and Clinical Transplantation. 2020; 18(3): 275 | | [Pubmed] | [DOI] | | | 44 |
Design of Multi-Epitope Vaccine against SARS-CoV-2 |
|
| Irini Doytchinova, Andrey Tchorbanov | | Cybernetics and Information Technologies. 2020; 20(6): 185 | | [Pubmed] | [DOI] | | | 45 |
nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics |
|
| Md. Tanvir Kabir, Md. Sahab Uddin, Md. Farhad Hossain, Jawaher A. Abdulhakim, Md. Asraful Alam, Ghulam Md Ashraf, Simona G. Bungau, May N. Bin-Jumah, Mohamed M. Abdel-Daim, Lotfi Aleya | | Frontiers in Cell and Developmental Biology. 2020; 8 | | [Pubmed] | [DOI] | | | 46 |
A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host |
|
| Rinki Minakshi, Arif Tasleem Jan, Safikur Rahman, Jihoe Kim | | Frontiers in Cellular and Infection Microbiology. 2020; 10 | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
|
